BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Lin Q, Dong M, Wen J, Wei L, Ma X, Chen Z, Wu X. Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. Leukemia & Lymphoma 2010;51:1678-85. [DOI: 10.3109/10428194.2010.499486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 . Bibliography. Lymphoma. Current world literature. Curr Opin Oncol 2011;23:537-41. [PMID: 21836468 DOI: 10.1097/CCO.0b013e32834b18ec] [Reference Citation Analysis]
2 Li X, Xing Y, Lin Q, Dong M, Wan X, Wu X. The treatment of severe hepatitis B virus reactivation after chemotherapy. Nat Rev Clin Oncol 2012;9:350-350. [DOI: 10.1038/nrclinonc.2012.1-c1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Thompson PA, Tam CS, Thursky K, Seymour JF. Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge. Leuk Lymphoma 2010;51:1592-5. [PMID: 20807092 DOI: 10.3109/10428194.2010.509456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Nabhan C, Smith SM, Kahl BS. Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies. Leuk Lymphoma 2012;53:770-8. [PMID: 21958083 DOI: 10.3109/10428194.2011.628061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
5 Boleto G, Saadoun D, Cacoub P. Strategies to prevent persistent or relapsed mixed cryoglobulinemia. Expert Opinion on Orphan Drugs 2020;8:137-43. [DOI: 10.1080/21678707.2020.1767586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wu X, Li X, Chen Z, Wen J, Lin Q, Xing Y, Dong M, Wei L, Wang T, Chen J, Lin Z, Wan X, Ruan D, Ma X. An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biol 2013;34:909-18. [DOI: 10.1007/s13277-012-0626-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C. Cryoglobulinaemia. Nat Rev Dis Primers 2018;4:11. [PMID: 30072738 DOI: 10.1038/s41572-018-0009-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 13.8] [Reference Citation Analysis]